Search research articles
Contact Us
Filters
Showing results (351-360 of 373) with videos related to
Page
of 38
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 24, 2021
[Impact of additional time spent for vaccination services on overall satisfaction rate in parents]
M Cao, J H Zhao, J Zhang, et al.
Diabetologia
|
April 14, 2007
Modified end-stage renal disease risk score for Chinese type 2 diabetic patients--the Hong Kong Diabetes Registry
X L Yang, W Y So, A P S Kong, et al.
Diabetologia
|
September 1, 2006
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry
X L Yang, W Y So, A P S Kong, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
March 27, 2022
[Metagenomic data-analysis reveals enrichment of lipopolysaccharide synthesis in the gut microbiota of atrial fibrillation patients]
K Zuo, J Zhang, C Fang, et al.
Journal of Gastroenterology
|
August 10, 2016
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection
Joji Toyota, Yoshiyasu Karino, Fumitaka Suzuki, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
March 13, 2020
[Guidelines for the use of post-traumatic tetanus vaccines and passive immune preparation]
C L Wang, S Liu, Z J Shao, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
December 5, 2019
[Guidelines for the use of post-traumatic tetanus vaccines and passive immune preparation]
C L Wang, S Liu, Z J Shao, et al.
British Journal of Cancer
|
July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
L R Molife, P C Fong, L Paccagnella, et al.
Journal of Gastroenterology and Hepatology
|
April 4, 2017
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Trials
|
September 2, 2025
Preoperative focused echocardiography on patients with fractured neck of femur. ECHONOF-III trial: study protocol for a multicenter randomized controlled trial
Ximena Cid-Serra, Alistair Royse, Andrea Bowyer, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 373) with videos related to
Sort By:
Page
of 38
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 24, 2021
[Impact of additional time spent for vaccination services on overall satisfaction rate in parents]
M Cao, J H Zhao, J Zhang, et al.
Diabetologia
|
April 14, 2007
Modified end-stage renal disease risk score for Chinese type 2 diabetic patients--the Hong Kong Diabetes Registry
X L Yang, W Y So, A P S Kong, et al.
Diabetologia
|
September 1, 2006
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry
X L Yang, W Y So, A P S Kong, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
March 27, 2022
[Metagenomic data-analysis reveals enrichment of lipopolysaccharide synthesis in the gut microbiota of atrial fibrillation patients]
K Zuo, J Zhang, C Fang, et al.
Journal of Gastroenterology
|
August 10, 2016
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection
Joji Toyota, Yoshiyasu Karino, Fumitaka Suzuki, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
March 13, 2020
[Guidelines for the use of post-traumatic tetanus vaccines and passive immune preparation]
C L Wang, S Liu, Z J Shao, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
December 5, 2019
[Guidelines for the use of post-traumatic tetanus vaccines and passive immune preparation]
C L Wang, S Liu, Z J Shao, et al.
British Journal of Cancer
|
July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
L R Molife, P C Fong, L Paccagnella, et al.
Journal of Gastroenterology and Hepatology
|
April 4, 2017
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Trials
|
September 2, 2025
Preoperative focused echocardiography on patients with fractured neck of femur. ECHONOF-III trial: study protocol for a multicenter randomized controlled trial
Ximena Cid-Serra, Alistair Royse, Andrea Bowyer, et al.
Page
of 38